Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombosis × Anticoagulants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombosis 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Ischemic Stroke 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cancer-associated Thrombosis 1 Adenocarcinoma 1

Interventions

apixaban 4 Heparin, Low-Molecular-Weight 3 Enoxaparin 3 Dalteparin 3 Blood Specimen Collection 3 Warfarin 2 Rivaroxaban 2 Aspirin 2 palbociclib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 X-Rays 1 Ultrasonography 1 Tinzaparin 1 Technetium Tc 99m Sulfur Colloid 1 Standard of Care 1 Simvastatin 1 Saline Solution 1 Physical Therapy Modalities 1 Photons 1 Phlebotomy 1 Paclitaxel 1 Observation 1 Musculoskeletal Manipulations 1 Injections 1 Hydroxyurea 1 Heparin 1 Fondaparinux 1 Docetaxel 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507645 2024-09-05

PUMICE

Beijing Tiantan Hospital

Phase 3 Completed

Ischemic Stroke, Lymphoma, Follicular, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡